These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 94502)

  • 1. Effect of irradiation and chemotherapeutic agents on the capillaries of Ehrlich ascites carcinoma of mice.
    Egawa J; Ishioka K; Ogata T
    Acta Radiol Oncol Radiat Phys Biol; 1979; 18(6):535-43. PubMed ID: 94502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of bleomycin on the cell cycle of Ehrlich ascites carcinoma.
    Nagatsu M; Richart RM; Lambert A
    Cancer Res; 1972 Sep; 32(9):1966-70. PubMed ID: 4118376
    [No Abstract]   [Full Text] [Related]  

  • 3. Uptake of main fractions of labelled bleomycin by solid Ehrlich ascites tumours in mice.
    Rembelska M; Liniecki J; Koniarek B; Krawczyk Z
    Nuklearmedizin; 1984 Jun; 23(3):127-9. PubMed ID: 6207486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The combined effect of peplomycin and X-ray irradiation].
    Munenaga Y
    Hiroshima Daigaku Shigaku Zasshi; 1984 Jun; 16(1):23-35. PubMed ID: 6206126
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of growth of Ehrlich ascites tumors in ICR-Ha Swiss mice by isocyanates.
    Moos GE; Maguire JA; Kitchlew TZ; Swyers WA; Volk PZ; Croft JR; Quigley MJ; Fries JR; Oser NA; Anderson LJ
    Cancer Res; 1971 Jul; 31(7):937-41. PubMed ID: 5560387
    [No Abstract]   [Full Text] [Related]  

  • 6. Cell synchronization in solid tumors.
    Schumann J; Ehring F; Gohde W
    Recent Results Cancer Res; 1975; (52):206-14. PubMed ID: 64995
    [No Abstract]   [Full Text] [Related]  

  • 7. Intraperitoneal noxytiolin as an experimental chemotherapeutic agent.
    Desai S; Jamieson CW
    Br J Surg; 1973 May; 60(5):350-1. PubMed ID: 4706478
    [No Abstract]   [Full Text] [Related]  

  • 8. Enhancement of the action of bleomycin using liposome with Ehrlich's ascites carcinoma in mice.
    Sur P; Roy DK
    Indian J Exp Biol; 1979 Sep; 17(9):952-3. PubMed ID: 94590
    [No Abstract]   [Full Text] [Related]  

  • 9. Uptake of labelled tallysomycin by solid Ehrlich ascites tumors in mice.
    Liniecki J; Rembelska M; Koniarek B
    Nuklearmedizin; 1983 Jun; 22(3):159-61. PubMed ID: 6194513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental studies into the effect of nitrous oxide on tumour cell growth.
    Parbrook GD
    Br J Anaesth; 1967 Jul; 39(7):549-53. PubMed ID: 6037371
    [No Abstract]   [Full Text] [Related]  

  • 11. [The radiosensitizing effect of mecytosine on Ehrlich tumor].
    Aleksandrov SN; Vershinina SF
    Vopr Onkol; 1971; 17(9):88-91. PubMed ID: 5138813
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of the combination of cisplatin and peplomycin on Ehrlich ascites carcinoma and on head and neck squamous cell carcinoma transplanted to nude mice].
    Mashino S
    Nihon Jibiinkoka Gakkai Kaiho; 1985 Apr; 88(4):502-11. PubMed ID: 2411898
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of implanted ethylene-vinyl alcohol copolymer matrices containing 5-fluorouracil on Ehrlich ascites carcinoma.
    Miyazaki S; Takeuchi S; Sugiyama M; Takada M; Hosokawa M; Koga Y; Kobayashi H
    J Pharm Pharmacol; 1985 Jan; 37(1):64-6. PubMed ID: 2858533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Animal experiments on ozone therapy of non-irradiated and irradiated tumors. II. Ehrlich ascites carcinoma in vivo].
    Grundner HG; Erler U
    Strahlentherapie; 1976 Jun; 151(6):522-9. PubMed ID: 942558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pimaricin potentiation of bleomycin activity against murine tumors.
    Komiyama K; Umezawa I; Kuwano M; Komiyama S
    Gan; 1983 Aug; 74(4):602-6. PubMed ID: 6195041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined effects of hyperthermia, bleomycin, and X rays on Ehrlich ascites tumor.
    Kai H; Matsufuji H; Sugimachi K; Okudaira Y; Inokuchi K
    J Surg Res; 1986 Nov; 41(5):503-9. PubMed ID: 2430140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new boron compound (guanidine biboric acid adduct) as an antitumour agent against Ehrlich ascites carcinoma in mice.
    Ghosh P; Sur B; Bag SP; Sur P
    Tumour Biol; 1999; 20(1):44-51. PubMed ID: 9858874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of the antitumor activity of 5-fluorouracil by drug combinations.
    Frankfurt OS
    Cancer Res; 1973 May; 33(5):1043-7. PubMed ID: 4267349
    [No Abstract]   [Full Text] [Related]  

  • 19. Bleomycin: mammalian cell lethality and cellular basis of optimal schedule.
    Takabe Y; Miyamoto T; Watanabe M; Terasima T
    J Natl Cancer Inst; 1977 Oct; 59(4):1251-5. PubMed ID: 71355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimitotic activity of the methylhydrazine derivative Natulan in the ehrlich ascites carcinoma; dose-effect relationship.
    Llombart A; Mínguez FP
    Oncology; 1969; 23(3):201-8. PubMed ID: 5785067
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.